TAS2R5: A Potential Drug Target and Biomarker (G54429)
TAS2R5: A Potential Drug Target and Biomarker
Tas2R5 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. This molecule plays a crucial role in the regulation of gene expression and has been shown to be involved in the development and progression of several diseases.
The RNA molecule was first identified in the human genome in 2008 and has since been shown to have similar patterns of expression to that of the protein encoded by the gene SMAD2. SMAD2 is a transcription factor that plays a role in the regulation of gene expression and has been shown to be involved in the development and progression of several diseases, including cancer.
Tas2R5 has been shown to be involved in the regulation of gene expression in various tissues and has been associated with the development of several diseases, including cancer. For example, studies have shown that high levels of Tas2R5 expression are associated with poor prognosis in breast cancer and that downregulation of Tas2R5 has been shown to improve survival in these patients.
In addition to its potential as a drug target, Tas2R5 has also been shown to be a potential biomarker for several diseases. For example, studies have shown that downregulation of Tas2R5 has been associated with poor prognosis in patients with colorectal cancer and that high levels of Tas2R5 expression are associated with the development of these cancers.
The potential of Tas2R5 as a drug target is based on its involvement in the regulation of gene expression and its association with the development and progression of several diseases. However, further research is needed to fully understand its potential and to develop safe and effective drugs that target Tas2R5.
In conclusion, Tas2R5 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Further research is needed to fully understand its potential and to develop safe and effective drugs that target this molecule.
Protein Name: Taste 2 Receptor Member 5
Functions: Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5
More Common Targets
TAS2R50 | TAS2R60 | TAS2R63P | TAS2R64P | TAS2R7 | TAS2R8 | TAS2R9 | TASL | TASOR | TASOR2 | TASP1 | Taste receptor type 2 | Taste Receptors Type 1 | TAT | TAT-AS1 | TATDN1 | TATDN2 | TATDN2P3 | TATDN3 | TAX1BP1 | TAX1BP3 | TBATA | TBC1D1 | TBC1D10A | TBC1D10B | TBC1D10C | TBC1D12 | TBC1D13 | TBC1D14 | TBC1D15 | TBC1D16 | TBC1D17 | TBC1D19 | TBC1D2 | TBC1D20 | TBC1D21 | TBC1D22A | TBC1D22A-AS1 | TBC1D22B | TBC1D23 | TBC1D24 | TBC1D25 | TBC1D26 | TBC1D27P | TBC1D28 | TBC1D29P | TBC1D2B | TBC1D3 | TBC1D30 | TBC1D31 | TBC1D32 | TBC1D3B | TBC1D3C | TBC1D3F | TBC1D3G | TBC1D3H | TBC1D3L | TBC1D3P1 | TBC1D3P2 | TBC1D4 | TBC1D5 | TBC1D7 | TBC1D8 | TBC1D8-AS1 | TBC1D8B | TBC1D9 | TBC1D9B | TBCA | TBCB | TBCC | TBCCD1 | TBCD | TBCE | TBCEL | TBCK | TBILA | TBK1 | TBKBP1 | TBL1X | TBL1XR1 | TBL1Y | TBL2 | TBL3 | TBP | TBPL1 | TBPL2 | TBR1 | TBRG1 | TBRG4 | TBX1 | TBX10 | TBX15 | TBX18 | TBX18-AS1 | TBX19 | TBX2 | TBX20 | TBX21 | TBX22 | TBX3